Lupin Overview

  • Founded
  • 1968
Founded
  • Status
  • Public
  • Employees
  • 18,302
Employees
  • Stock Symbol
  • 500257
Stock Symbol
  • Investments
  • 24
  • Share Price
  • $16.50
  • (As of Wednesday Closing)

Lupin General Information

Description

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The vast majority of the company's sales are derived from its Advance Markets Formulations segment, followed by Domestic Formulations. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Contact Information

Website
www.lupin.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Stock Exchange
BOM
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lupin Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.50 $16.29 $11.00 - $16.96 $7.49B 454M 171K $0.36

Lupin Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019
EV 6,242,977 6,242,977 4,064,302 5,559,595
Revenue 2,006,318 2,006,318 2,131,273 2,058,727
EBITDA 363,508 363,508 320,869 350,330
Net Income 163,512 163,512 (37,915) 86,659
Total Assets 3,214,675 3,312,629 4,024,430
Total Debt 0 417,391 878,430 1,223,361
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lupin Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lupin‘s full profile, request access.

Request a free trial

Lupin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and
Pharmaceuticals
18,302 As of 2020
000000000

00000

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse c
0000 000000000
Mumbai, India
00000 As of 0000
00000000

000000 0

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000000000000
Mumbai, India
0000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lupin Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cipla Corporation Mumbai, India 00000 00000000
000000 000000 Corporation Mumbai, India 0000
00000 000000 Corporation Ahmedabad, India 00000 00000000
000000000 000000 Corporation Hyderabad, India 00000 00000 000000000 00000
00000000 0000 0000 Corporation Noida, India 0000 00000 00000000000 00000
You’re viewing 5 of 22 competitors. Get the full list »

Lupin Executive Team (21)

Name Title Board Seat Contact Info
Vinita Gupta Chief Executive Officer & Board Member
Vinod Dhawan President Asia Africa Middle East and Latin America
Krunal Parekh General Manager, Operations (APAC & Japan), Business Development, Mergers and Acquisitions
Nilesh Gupta Managing Director
Alan Butcher Chief Corporate Development Officer
You’re viewing 5 of 21 executive team members. Get the full list »

Lupin Board Members (11)

Name Representing Role Since
000000 000000 Self Independent Director 000 0000
0000-000 000000000 Self Independent Director 000 0000
00000 000000 00.0 Lupin Vice Chairman 000 0000
0.0.0. 00000 Lupin Board Member 000 0000
0. 0. 0000 00.0 Self Independent Director 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Lupin Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lupin Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Lupin‘s full profile, request access.

Request a free trial

Lupin Investments & Acquisitions (24)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 11-Oct-2017 000000000000000000 00000 Drug Discovery 000000 00000
00000000 & 0000000 03-Aug-2016 000000000 00000 00 00000 Buildings and Property 000000 00000
0000000 00000'0 (0 24-Jul-2015 000000000000000000 Medical Supplies 000000 00000
00000 000000000000 23-Jul-2015 000000000000000000 00000 Pharmaceuticals 000000 00000
Novel Laboratories 23-Jul-2015 Merger/Acquisition Pharmaceuticals 000000 00000
You’re viewing 5 of 24 investments and acquisitions. Get the full list »

Lupin Subsidiaries (8)

Company Name Industry Location Founded
Symbiomix Therapeutics Drug Discovery Newark, NJ 2012
00000 000000000000 Pharmaceuticals Franklin Township, NJ 0000
00000 000000000000 Pharmaceuticals Franklin Township, NJ 0000
0000000 000000 Distributors (Healthcare) Camberwell, Australia 0000
000000 Drug Delivery Oldenzaal, Netherlands 0000
You’re viewing 5 of 8 subsidiaries. Get the full list »

Lupin Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000 000000000000 10-Oct-2007 0000000000 Completed
  • 2 buyers
To view Lupin’s complete exits history, request access »